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The Relationship between Alexithymia and General 
Symptoms of Patients with Depressive Disorders 
 
 
 
ObjectiveᄏDepression has been associated with alexithymic features. However, few studies 
have investigated the differences in the general symptoms of patients with depressive disor-
ders according to the presence of alexithymia. Thus, the aim of this study was to evaluate the 
relationship between alexithymia and symptoms experienced by patients with clinically 
diagnosed depressive disorders. 
MethodsᄏA chart review of patients who were evaluated using the Korean version of the 
20-item Toronto Alexithymia Scale (TAS-20) and Symptom Checklist 90-Revised (SCL-90-
R) at the same time between the years 2003 and 2007 was conducted. A total of 104 patients 
with depressive disorders were included and divided into two groups: alexithymia (n=52) and 
non-alexithymia (n=52). A direct comparison between the two groups was carried out. Re-
gression analysis was also carried out for the TAS-20 total and subset scores in order to model 
the relationship between alexithymia and symptoms. 
ResultsᄏThe presence of alexithymia was confirmed in 50% of the patients with depres-
sive disorders, and the symptoms of depressive patients with alexithymia were more severe 
than those of their non-alexithymic counterparts on all 9 symptom domains of the SCL-90-R. 
Furthermore, regression analysis revealed that the presence of alexithymia was positively asso-
ciated with depression, phobic anxiety, and psychoticism but inversely associated with anxiety. 
ConclusionᄏThese results suggest that the clinical features of depression are partially de-
pendent on the presence of alexithymia. Alexithymic patients with depressive disorders are 
likely to show more severe depressive, psychotic, and phobic symptoms. In other words, cli-
nicians should suspect the presence of alexithymic tendencies if these symptoms coexist in 
patients with depressive disorders and address their difficulties in effective communication. 
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Introduction 
 
Alexithymia, a term originally derived from Latin, is the inability to describe emo-
tions with words. Sifneos, who formerly defined the clinical features of alexithymia,
positioned this concept in a theoretical framework with Nemiah in 1970.
1,2 Alexithy-
mia is a multidimensional personality construct characterized by three core features:
a) difficulty identifying emotions and distinguishing between emotions and bodily
sensations, b) difficulty describing or communicating emotions to others, and c) an 
externally oriented style of thinking.
3 Alexithymia has important clinical implica-
tions, as it not only creates interpersonal problems but also limits the responsiveness
of those having alexithymic tendencies to psychotherapy. Therefore, early identifica-
tion and modification of alexithymic tendencies are necessary to improve the thera-
peutic relationship and, consequently, treatment outcome. 
To date, depression has been identified as the psychiatric feature most consistently
associated with alexithymia. Previous literature has indicated that there is a strong 
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association between depression and alexithymia in both 
depressive patients
4-6 and general populations.
7-9 Longi-
tudinal studies in patients with depressive disorder also 
showed that recovery from depression was associated with 
a decrease in alexithymic features.
4,6 Several studies have 
revealed a positive relationship between depression and 
the level of difficulty identifying and describing feelings. 
However, in general, the lack of an imaginative capacity 
and externally oriented thinking style are not related to de-
pression.
10-12 One prospective study showed that difficulties 
in identifying and describing feelings are associated with 
changes in mood, while externally oriented thinking is not.
6 
In the clinical world, patients with depressive disorders 
do not solely suffer from psychiatric symptoms measured 
by the Beck Depression Inventory (BDI), which was used 
in most studies demonstrating the relationship between 
depression and alexithymia. For instance, psychotic fea-
tures are estimated to be present in approximately 12% 
to 25% of patients with depressive disorders.
13,14 Anxiety 
symptoms are also common in patients with major depres-
sion: 62% present with psychic anxiety, 42% have soma-
tic anxiety, and 29% have panic attacks.
15 However, since 
most of the previous studies regarding the relationship 
between depressive disorder and alexithymia only used 
the BDI to evaluate depressive disorder, the relationship 
between general symptoms and alexithymia in patients 
with depressive disorder has scarcely been studied. Hon-
kalampi et al. reported that alexithymic patients with de-
pressive disorders showed more overall psychopathology 
(anxiety, hostility, psychotic symptoms, and somatization) 
and severe depression than their nonalexithymic coun-
terparts.
5 Grabe et al. revealed that a broad range of current 
psychopathology is associated with difficulties identify-
ing feelings in subjects with 9 different psychiatric disor-
ders.
16 However, the meanings of these two studies were 
limited in that the former was conducted in inhomoge-
neous psychiatric patients, and the latter did not consider 
the dimensions of alexithymia. 
Therefore, the aim of this study was to evaluate the re-
lationship between alexithymia and the general symp-
toms experienced by patients with depressive disorders. 
We hypothesized that patients with depressive disorders 
and alexithymia would have different symptoms and ma-
nifestations than patients with depression but no alexi-
thymia and that a certain dimension of alexithymia would 
be related to a specific symptom. 
 
Methods 
 
Subjects 
This study included 104 patients diagnosed with depres-
sive disorders. Sixty-two of the patients were male and 
42 were female, and their mean age was 39.9±16.1 
years (range, 18-76 years). The primary diagnosis was 
major depressive disorder in 40 patients, dysthymic dis-
order in 35 patients, and depressive disorder not other-
wise specified (NOS) in 29 patients. The mean Clinical 
Global Impression (CGI) score was 3.5±1.0, which was 
indicative of mild to moderate illness. Only 12 patients 
were not being treated with psychiatric medication; 86 
patients were taking antidepressants at therapeutic dosa-
ges, most of whom (n=71) were also taking anxiolytic 
medications; two patients were only taking antipsycho-
tic medications, and two patients were taking only anxi-
olytic medications. Table 1 shows the demographic and 
clinical characteristics of the sample. 
TABLE 1. Demographic and clinical characteristics of patients 
with depressive disorders (N=104) 
Variables 
Number or   
mean (SD) 
Range or 
percent 
Gender (male/female) 62/42   
Age (year) 39.9  (16.1) 18-76 
Level of education (year) 11.4  (03.6)  00-18 
Main DSM-IV Axis I diagnosis 
  (MDD/DYS/DDNOS) 
40/35/29 
 
 
Presence of psychiatric 
 comorbid  disorder 
39 
 
37.5% 
 
Duration of illness (year)  03.2 (03.9) 0.1-22 
CGI score  03.5 (01.0)  02-60 
Medication* Number 
Daily dose (mg), 
mean (SD) 
  Antidepressants    
    Sertraline 29  56.9  (29.0) 
    Escitalopram 16  09.4 (04.8) 
    Paroxetine 14  15.2  (05.0) 
    Venlafaxine 11  68.2  (32.8) 
    Mirtazapine  08 10.3  (03.9) 
    Citalopram  04 10.1  (08.0) 
    Trazodone  03 25.0  (00.0) 
    Fluoxetine  02 30.0  (14.1) 
    Bupropion  01 150  (00.0) 
  Antipsychotics    
    Quetiapine  06 68.8  (71.5) 
    Risperidone  03  02.3 (02.3) 
    Olanzapine  01 12.5  (00.0) 
  Anxiolytics    
    Alprazolam 39  00.3 (00.1) 
    Clonazepam 25  00.6 (00.2) 
    Buspirone 10  14.0  (02.1) 
    Diazepam  01  04.0 (00.0) 
*12 patients were not taking any psychiatric medications at the 
time of their psychological evaluation. SD: standard deviation, 
DSM-IV: Diagnostic and Statistical Manual of Mental Disorders, 
fourth edition, MDD: major depressive disorder, DYS: dysthymic 
disorder, DDNOS:  depressive disorder not otherwise specified, 
CGI: Clinical Global Impression 
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Procedures 
All patients met the Diagnostic and Statistical Manual 
of Mental Disorders, fourth edition (DSM-IV) criteria for 
a primary diagnosis of a depressive disorder and were 
evaluated in a single session using the Korean version 
of the 20-item Toronto Alexithymia Scale (TAS-20K)
17 
and the Symptom Checklist 90-Revised (SCL-90-R)
18 
at Kyungpook National University Hospital, Daegu, Korea, 
between January 2003 and March 2007. Detailed chart 
reviews were also conducted for all participants. The ex-
clusion criteria included age under 18 years, mental retar-
dation, and any neurological condition that might affect 
self-reporting.  
Data on demographic and psychosocial factors (i.e., 
sex, age, and level of education), clinical profiles (i.e., 
primary and comorbid psychiatric diagnoses present dur-
ing the evaluation according to DSM-IV criteria, dura-
tion of illness, medications and CGI scores), and results 
of psychological assessments (TAS-20K, SCL-90-R) were 
analyzed. 
Two experienced psychiatrists (K.J.H., K.H.W.) re-
viewed the patients’ charts, newly confirmed the previous 
diagnosis of depressive disorders, and rated their CGI 
scores at the time the TAS-20 was conducted based on 
chart review. Ninety-nine patients (95%) completed these 
assessments at the time of their first psychiatric visit. This 
study was approved by the institutional review board of 
Kyungpook National University Hospital. 
 
Psychological scales 
 
The 20-item Toronto Alexithymia Scale 
The TAS-20 has become the most widely used meas-
ure of alexithymia.
3 This self-report questionnaire meas-
ures three intercorrelated dimensions of the alexithymia 
construct: a) difficulties identifying feelings, b) difficul-
ties describing feelings, and c) externally oriented think-
ing. Each TAS-20 item was rated on a 5-point Likert 
scale, with total scores ranging from 20 to 100. The cut-
off point for alexithymia was ≥61.
19 The study by Lee 
and colleagues
17 provided a detailed report concerning 
the translation of the TAS-20 into Korean. Using confirm-
atory factor analysis, Lee et al. showed that the three-
factor structure of the original scale is consistent with the 
Korean version of the scale (Cronbach’s alpha=0.76). 
 
Symptom Checklist-90-Revised 
The SCL-90-R is one of the most widely used and well-
validated self-report symptom inventories designed to 
evaluate a broad range of psychological problems and 
symptoms of psychopathology.
20 Respondents rate 90 
items using a 5-point scale (1=“no problem” to 5=“very 
serious”) to measure the extent to which they have ex-
perienced the listed symptoms in the past 7 days. It con-
sists of 9 symptom scales (Somatization, Obsessive-Com-
pulsive, Interpersonal Sensitivity, Depression, Anxiety, 
Hostility, Phobic Anxiety, Paranoid Ideation, and Psy-
choticism) and 3 global indices [Global Severity Index 
(GSI), Positive Symptom Distress Index (PSDI), and 
Positive Symptom Total (PST)]. Higher scores on the 
SCL-90-R are indicative of greater psychological distress. 
The internal consistency (coefficient alphas) for the nine 
symptom dimensions ranged from 0.77 for psychoticism, 
to a high of 0.90 for depression. The Korean version of 
the SCL-90-R was used in this study.
18  
 
Clinical Global Impression-Severity Scale 
The CGI-Severity (CGI-S)
21 was used to assess the 
clinical impression of the current state of the patient’s 
illness. The rater was asked to “consider his total clini-
cal experience with the given population.” The time span 
considered is the week prior to the rating; and the fol-
lowing scores can be given: 1=normal, not at all ill; 2= 
borderline mentally ill; 3=mildly ill; 4=moderately ill; 
5=markedly ill; 6=severely ill; and 7=among the most 
extremely ill patients. 
 
Statistical analysis 
Based on their TAS-20 scores, the subjects were di-
vided into two groups, alexithymia (TAS-20K total score 
≥61) and non-alexithymia (TAS-20K total score <61). 
Between-group comparisons were performed using the 
chi-square test for categorical variables and independent 
t-test for continuous variables. To identify certain symp-
toms associated with alexithymia, multiple linear regres-
sion analysis was used to model the relationship between 
alexithymia and symptoms. Age, education level, duration 
of illness, and the presence of comorbid psychiatric dis-
order were also included to adjust for confounding ef-
fects. Regression analyses were carried out for total score 
and score on each of the three subfactors in the TAS-20. 
Statistic analyses were performed using SPSS software 
(version 12.0; SPSS Inc., Chicago, IL) All significant 
levels were two-tailed and set at a 0.05 significance level. 
 
Results 
 
Between-group comparisons 
The only significant difference between the alexithymia 
and non-alexithymia groups was the ratio of comorbid 
psychiatric disorder (t=5.0, p=0.026) to duration of ill-
ness (t=0.2, p=0.040). There were no significant group 
differences in the demographic and clinical characteris-
tics of the patients. The patients with depressive disor- 
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ders and alexithymia showed a significant increase on 
all 9 of the items on the SCL-90-R compared to those 
without alexithymia (all ps<0.001)(Table 2).  
 
Multiple linear regression analysis 
Multiple linear regression analysis was carried out us-
ing the simultaneous entry method. In terms of total score 
on the TAS-20, this analysis produced a value of 0.695 
for R
2, indicating that approximately 70% of the variance 
was accounted for by the independent variables (F13,90= 
15.77, p<0.001; adjusted R
2=0.651). After adjusting for 
possible confounders, total TAS-20 score was positively 
associated with depression, phobic anxiety, and psycho-
ticism and inversely associated with anxiety, among the 
9 dimensions of the SCL-90-R. Factor 1 was associated 
with somatization and showed a trend towards associa-
tion with psychoticism. Factor 2 was positively associated 
with depression and negatively associated with anxiety. 
Factor 3 was positively associated with psychoticism and 
negatively associated with anxiety (Table 3). 
 
Discussion 
 
In this study, we explored the relationship between 
alexithymia and the general symptoms of patients with 
depressive disorders. The presence of alexithymia was 
confirmed in 50% of patients, and the alexithymic patients 
with depressive disorders showed more severe symptoms 
in all 9 symptom domains of the SCL-90-R than their non-
alexithymic counterparts. Furthermore, regression analy-
sis revealed that the presence of alexithymia was posi-
tively associated with depression, phobic anxiety, and psy-
choticism, but inversely associated with anxiety. 
Fifty-two (50%) of the 104 patients with depressive 
disorders were considered alexithymic, and the patients’ 
scores on the SCL-90-R revealed a greater incidence of 
psychopathology on all 9 SCL-90-R subscales in alexi-
thymic patients than in nonalexithymic patients. These 
findings are generally consistent with those of a previous 
study showing that alexithymic patients with depressive 
disorders had a greater incidence of comorbid psychiatric 
disorder than their nonalexithymic counterparts.
5 Thus, 
these findings suggest that, even among depressive pa-
tients, the presence of alexithymic tendencies is related 
to more severe psychopathologies. It is important to note 
that there were no between-group differences in CGI sc-
ore and the proportion of depressive diagnoses. 
The symptom of depression, measured by the SCL-
TABLE 2. Comparison between non-alexithymia and alexithymia group among patients with depressive disorder 
Non-alexithymia Alexithymia  Statistics 
 
N=52 N=52 df  χ2 or t  p 
Gender (male/female) 29/23  33/19  001 0.6 0.424 
Age (year) 42.7  (13.9) 37.2  (17.7)  102 1.7 0.084 
Level of education (year) 12.1  (03.3) 10.8  (03.8)  102 1.8 0.078 
Main DSM-IV Axis I diagnosis (MDD/DYS/DDNOS) 19/18/15  21/17/14  002 0.2 0.922 
Presence of comorbid psychiatric disorder  14 (26.9%) 25  (48.1%)  001 5.0 0.026 
Duration of illness (year)  03.9 (04.9)  02.4 (02.2)  102 0.2 0.040 
CGI score  03.5 (01.0)  03.5 (00.9)  102 0.2 0.838 
Toronto Alexithymia Scale-20           
 TAS  total  51.3  (07.3) 69.4  (06.0) 102  -13.9  <0.001 
  TAS factor 1  17.0 (04.4) 26.4  (04.2) 102  -11.1  <0.001 
  TAS factor 2  14.0 (03.5) 19.0  (03.0) 102 -7.7  <0.001 
  TAS factor 3  20.2 (03.5) 24.0  (03.7) 102 -5.3  <0.001 
Symptom Checklist-90-R           
 Somatization  54.3  (13.6) 69.3  (13.7) 102 -5.6  <0.001 
 Obsessive-compulsive  54.3  (10.2) 69.4  (13.2) 102 -6.5  <0.001 
 Interpersonal  sensitivity  52.4  (11.6) 72.6  (15.9) 102 -7.4  <0.001 
 Depression  58.6  (11.3) 75.4  (13.6) 102 -6.9  <0.001 
 Anxiety  55.9  (10.8) 72.3  (15.9) 102 -6.2  <0.001 
 Hostility  52.3  (09.5) 69.1  (15.6) 102 -6.6  <0.001 
 Phobic  anxiety  52.1  (13.3) 76.2  (19.9) 102 -7.2  <0.001 
 Paranoid  ideation  51.0  (11.0) 71.8  (15.3) 102 -7.9  <0.001 
 Psychoticism  52.1  (10.0) 70.6  (13.9) 102 -7.8  <0.001 
Figures in parenthesis represent standard deviations except one variable of the presence of comorbid psychiatric disorder. DSM-IV: 
Diagnostic and Statistical Manual of Mental Disorders, fourth edition, MDD: major depressive disorder, DYS: dysthymic disorder, DDNOS:
depressive disorder not otherwise specified, CGI: Clinical Global Impression, TAS: Toronto Alexithymia Scale 
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90-R, was positively associated with TAS-20 total score 
and factor 2 (difficulties describing feelings) in this study. 
By definition, the depression item includes loss of energy, 
diminished interest and suicidal ideation, and these are 
consistent with the manifestations of depressive disorders. 
These findings mean that, even in patients with depres-
sive disorders, the more severe the alexithymia, the more 
severe the depression. Furthermore, these findings cor-
roborate the observation of Honkalampi et al.
5 More 
precisely, Sayar et al.
22 showed that individuals with al-
exithymic characteristics who had difficulty distinguish-
ing feelings from bodily sensations displayed more suicid-
al ideation related to hopelessness.   
In particular, subjects having difficulties describing their 
feelings were found to suffer from more depressive symp-
toms in this study. Duddu et al.
11 reported that patients 
with depressive disorder had greater difficulty describ-
ing their feelings when compared to subjects with soma-
toform disorder. Bankier et al.
10 also showed that de-
pression was significantly associated with factor 2. The 
results of previous studies and ours indicated that factor 
2 in the alexithymic construct may be more specifically 
related to depressive symptoms. 
Another item that was associated with alexithymia in 
this study was the psychoticism domain, which showed 
a positive relationship with total TAS-20 score and fac-
tor 3 (externally oriented thinking). This dimension in-
cludes isolation, withdrawal, schizoid lifestyle, hallucina-
tion and thought broadcasting. When compared with the 
paranoid ideation domain, it seems that psychoticism 
reflects behavioral (i.e., negative psychotic features) or 
perceptual symptoms rather than the content of thought 
shown in paranoid ideation. Nkam et al. observed that 
negative schizophrenic patients had significantly higher 
total scores in alexithymia than those with positive symp-
toms,
23 and these results seem to agree with our research 
findings. More importantly, factor 3 was significantly 
associated with psychoticism. Factor 3, which is decom-
posed into two factors, pragmatic thinking and lack of 
subjective significance or importance of emotions, is re-
lated to constricted imaginal processes, as evidenced by 
a paucity of fantasies.   
Thus, factor 3 may be closely related to anhedonia, po-
verty of thought, and alogia, which are also characteristics 
of the negative symptoms of schizophrenia. We assumed 
that this is the reason why factor 3 was specifically asso-
ciated with psychoticism. In this context, some studies 
concluded that a deficit in the ability to experience emo-
tions may contribute to interpersonal or social isolation, 
limited social engagement, and other impoverished en-
vironments.
24,25 However, there were also several studies 
that failed to show a relationship between alexithymia 
and negative symptoms.
26,27 
Interestingly, the phobic anxiety dimension of the SCL-
90-R was positively associated with TAS-20 total score 
while the anxiety dimension was inversely correlated with 
TAS-20 total score, factor 2 (difficulties describing feel-
ings) and factor 3 (externally oriented thinking). Anxiety 
includes general signs of anxiety such as nervousness, 
tension and trembling, while phobic anxiety is defined 
as a persistent fear response that is irrational and dispro-
portionate to the stimulus and is very similar in definition 
to agoraphobia. Although Devine et al.
28 observed that 
the degree of difficulty in recognizing and identifying 
TABLE 3. Relationships of TAS-20 total scores and subfactors with 9 symptom dimensions (simple regression analyses) 
TAS totala    Factor 1b    Factor 2c   Factor  3d 
 
B SE  B  β    B SE  B  β    B SE  B  β  B  SE  B  β 
Constant 27.05  5.73     0.76  3.66      5.26  2.56     21.04  3.13   
Somatization 0.11  0.06  -0.15    0.11  0.04  -0.26**    0.04  0.03  -0.17   -0.04 0.03  -0.17 
Obsessive-compulsive 0.09  0.10  -0.11    0.01  0.06  -0.02    0.08  0.04  -0.29   -0.01 0.05  -0.02 
Interpersonal sensitivity  0.09  0.09  -0.14    -0.03  0.06  -0.09    0.06  0.04  -0.26   0.06 0.05  -0.26 
Depression 0.28  0.10  -0.38**    0.08  0.07  -0.19    0.11  0.05  -0.39*   0.09  0.06  -0.35 
Anxiety  -0.24  0.10  -0.34*    0.02  0.06  -0.06    -0.11  0.04  -0.42*  -0.16 0.05  -0.62** 
Hostility 0.01  0.08  -0.02    -0.02  0.05  -0.06    -0.01  0.03  -0.02   0.04 0.04  -0.15 
Phobic anxiety  0.13  0.05  -0.23*    0.05  0.03  -0.17    0.03  0.02  -0.18   0.04 0.03  -0.21 
Paranoid ideation  -0.10  0.09  -0.16    0.00  0.06  -0.00    -0.05  0.04  -0.20   -0.06 0.05  -0.24 
Psychoticism 0.25  0.10  -0.34*    0.12  0.06  -0.29    0.02  0.04  -0.07   0.11 0.05  -0.42* 
Duration of illness  -0.28  0.18  -0.10    -0.12  0.11  -0.07    -0.15  0.08  -0.14   -0.01 0.10  -0.01 
Age  -0.05  0.05  -0.07    0.00  0.03  -0.00    -0.01  0.02  -0.04   -0.04 0.03  -0.14 
Education  -0.27  0.22  -0.09    -0.05  0.14  -0.03    0.01  0.10  -0.01   -0.23 0.12  -0.20 
Psychiatric comorbidity  1.34  1.42  -0.06    1.04  0.90  -0.08    0.55  0.63  -0.07   -0.24 0.77  -0.03 
a: R2=0.695 (p<0.01), b: R2=0.613 (p<0.001), c: R2=0.530 (p<0.001), d: R2=0.313 (p=0.001). *p<0.05, **p<0.01. TAS: Toronto Alexithymia 
Scale 
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feelings corresponded to the anxiety level of individuals, 
there was a negative relationship between the difficulty 
in communicating feelings and the intensity of anxiety 
symptoms in other studies.
22,29 Based on the findings of 
previous studies and ours, we speculate that, as anxiety 
increases to a certain extent, it makes individuals feel 
dystonic to their symptoms (internally oriented thinking), 
and they therefore overly recognize and describe their 
feelings. In effect, individuals who experience difficulty 
in communicating their feelings avoid relationships us-
ing various avoidance/escape methods, and thereby de-
crease their anxiety level.
22,29 Once anxiety surges to a 
degree of phobic state, people would be confused about 
their emotional state and make frantic efforts to avoid a 
given situation.   
The ‘Somatization’ category of the SCL-90-R was only 
associated with factor 1 (difficulties identifying feelings). 
Emotional deficits of alexithymic depressive patients un-
derlie failures in the capacity to recognize physical sen-
sations as the somatic manifestations of emotions. Con-
sequently, choosing not to deal with the emotions that 
underlie these somatic sensations results in somatosen-
sory amplification, which may then be misinterpreted as 
physical illness.
19,30 Our study findings also supported 
these interpretations. Due to their difficulty experienc-
ing emotions, alexithymic patients with depressive disor-
ders are thought to focus on somatic manifestations of 
emotional arousal, resulting in amplification of bodily 
sensations and misinterpretation of somatic sensations 
as signs of physical illness.
30 
The limitations of the present study are as follows. 
The major limitation of this study is its cross-sectional 
nature, which makes a causal inference impossible. Se-
cond, although we thoroughly reviewed data and dis-
carded improper data, some data such as diagnosis and 
disease severity could be biased due to the retrospective 
study design. Finally, the sample population was com-
prised of patients from Kyungpook National University 
Hospital, which makes it difficult to generalize this study 
to the general psychiatric population, and a selection bias 
may have occurred because more severe patients tend to 
be referred to university hospitals in Korea.   
In conclusion, the results of the present study indicate 
that the clinical features of depression partially depend 
on the presence of alexithymia. Alexithymic patients with 
depressive disorders are likely to show more severe de-
pressive, psychotic, and phobic symptoms. In other words, 
clinicians should suspect the presence of alexithymic 
tendencies if these symptoms coexist in patients with 
depressive disorders, and consider specific psychothera-
peutic techniques for improving affect differentiation in 
order to enhance effective communication.   
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